September 30, 2024

Can L-DOPA Protect Against nAMD?

Patients consistently treated with L-DOPA also had lower progression rates from intermediate AMD to nAMD compared to non-treated groups.

Conexiant

September 30, 2024

Proposed Aflibercept Biosimilar Shows Comparable Safety and Efficacy to Eylea for nAMD

52-Week Results from MYLIGHT

Conexiant

September 23, 2024

MCO-010 Advances to Phase 3 for Stargardt Macular Degeneration

Nanoscope Therapeutics is set to initiate its first randomized, controlled gene therapy trial for the mutation-agnostic approach to treatment.

Conexiant

September 18, 2024

Assessing the Impact of iRORA Lesions on Retina Sensitivity and Function

A new case study explores the impact of incomplete retinal pigment epithelium and outer retinal atrophy lesions on retinal sensitivity in intermediate age-related macular degeneration, shedding light on potential surrogate markers for retinal dysfunction. (Source: BMJ Open Ophthalmology)

Conexiant

September 09, 2024

Vision Impairment Linked to Nearly One-Fifth of Dementia

Vision impairment, particularly contrast sensitivity deficits, may account for up to 19% of dementia cases in older US adults, suggesting a potential target for prevention strategies.

Conexiant

October 01, 2023

Preventing Conversion to Advanced AMD

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

March 01, 2024

AI’s Impact + Influence: Web Exclusive 

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Eyecare Business

June 10, 2024

Melatonin May Reduce Age-related Macular Degeneration Risk

Melatonin use is associated with a reduced risk of developing and progressing age-related macular degeneration.

Conexiant

June 11, 2024

Eye Pain: A Major Contributor to Outpatient and Emergency Visits

This study analyzes over 5 million annual eye pain-related visits to U.S. outpatient and emergency departments, highlighting the prevalence and non-vision-threatening nature of most cases.

Conexiant